RGS18: Regulator of G Protein Signaling 18

A key modulator of platelet function and hematopoietic signaling

Gene Information Card

Symbol RGS18
Full Name Regulator of G Protein Signaling 18
Gene Type Protein coding
Chromosomal Location 1q31.2
NCBI Gene ID 64407 ncbi.nlm.nih.gov/gene/64407
Ensembl ID ENSG00000150681
UniProt ID Q9NS28
OMIM ID 607189
HGNC ID 14623
Aliases RGS13, RGS20, FLJ22955

Description

RGS18 (Regulator of G Protein Signaling 18) is a member of the RGS protein family that accelerates the GTPase activity of G protein alpha subunits, thereby negatively regulating G protein-coupled receptor (GPCR) signaling. It is predominantly expressed in hematopoietic tissues, particularly in platelets and megakaryocytes, where it modulates platelet activation and aggregation. RGS18 also plays roles in immune cell signaling and has been implicated in thrombotic and inflammatory disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Thrombocytopenia RGS18 loss-of-function may impair platelet production or activation, leading to low platelet counts. ClinVar, OMIM
Bleeding disorders Dysregulation of RGS18-mediated GPCR signaling can alter platelet aggregation and hemostasis. NCBI Gene, PubMed
Myeloproliferative neoplasms Altered RGS18 expression may contribute to abnormal megakaryocyte proliferation. COSMIC, literature

Expression Profile

Tissue Expression
Tissue nTPM level
Bone marrow 12.5 Medium
Spleen 8.3 Low
Whole blood 6.7 Low
Lung 2.1 Not detected
Liver 1.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
HEK 293 0.2 Low expression; used for recombinant studies
K562 4.8 Moderate; erythroleukemia cell line
MEG-01 9.1 High; megakaryocytic lineage
THP-1 3.5 Monocytic; moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.553C>T (p.Arg185Trp) Missense <0.01% Unknown; predicted damaging by SIFT
c.412G>A (p.Glu138Lys) Missense <0.01% Unknown; may affect GAP activity
c.1A>G (p.Met1Val) Start loss <0.01% Likely loss of function
Mutation functional classification

Loss of Function (LOF)

Start loss mutations (e.g., p.Met1Val) and missense variants that disrupt the RGS domain are predicted to impair GTPase-accelerating activity, leading to prolonged GPCR signaling.

Gain of Function (GOF)

No gain-of-function mutations have been reported in RGS18.

Dominant Negative (DN)

No dominant-negative mutations have been characterized for RGS18.

Gene Ontology (GO)

• GTPase activator activity • G protein-coupled receptor signaling pathway
• negative regulation of signal transduction • regulation of platelet activation
• intracellular signal transduction

Pathways

GPCR downstream signaling
Platelet activation
signaling and aggregation
G alpha (i) signaling events

Protein Summary

RGS18 is a 235-amino acid protein containing a conserved RGS domain that interacts with Gα subunits (particularly Gαi and Gαq) to accelerate GTP hydrolysis, thereby terminating GPCR signaling. It is highly expressed in platelets and megakaryocytes, where it regulates thrombus formation. RGS18 also modulates chemokine receptor signaling in immune cells. Structural studies show that its N-terminal region is important for membrane localization and receptor selectivity.

Related Products

Product name Cat.No. Species Gene ID
RGS18 Knockout HEK293 Cell Line EDJ-KQ15056 Human 64407 Details Get a Quote
RGS18 Knockout HeLa Cell Line EDJ-KQ57054 Human 64407 Details Get a Quote
RGS18 Knockout A-549 Cell Line EDJ-KQ65567 Human 64407 Details Get a Quote
RGS18 Knockout HCT 116 Cell Line EDJ-KQ73996 Human 64407 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: